Filing Details
- Accession Number:
- 0001209191-15-083420
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-03 21:02:25
- Reporting Period:
- 2015-12-01
- Filing Date:
- 2015-12-03
- Accepted Time:
- 2015-12-03 21:02:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Transaction Summary
| Sold: | 5,000 shares | Avg. Price: $131.00 | Total Value: $655,000.00 |
| Number of Shares After Transactions: | 75,000 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-01 | 5,000 | $72.14 | 80,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-01 | 5,000 | $131.00 | 75,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-12-01 | 5,000 | $0.00 | 5,000 | $72.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,500 | 2024-05-31 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
- Fully vested.
Billionaire Hedge Funds
